Skip to primary content

Alzheimer Headlines

the source for all your Alzheimer news

Alzheimer Headlines

Main menu

  • Home
  • About us
  • Read more here
  • Video
  • Caregiver’s guide to protecting an Alzheimer’s patient finances

Post navigation

← Previous Next →

What Alzheimer’s disease drugs are in development next trial – Business Insider

Posted on October 9, 2017 by Leo Valk

Axovant’s trial results are the last major results to come out in 2017, with the next ones reading out in 2018 and a major wave of results expected in 2019.

Source: What Alzheimer’s disease drugs are in development next trial – Business Insider

This entry was posted in Alzheimer Overview, Research by Leo Valk. Bookmark the permalink.

RSS Alzforum – Papers of the Week: 29 Jul – 4 Aug 2022

  • c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases.
  • A four-month home-based tDCS study on patients with Alzheimer's disease.
  • Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Creutzfeldt-Jakob Disease: A Systematic Review and Meta-Analysis.
Privacy Policy Proudly powered by WordPress